Literature DB >> 6143984

Impact of rubella vaccination in Australia.

M A Menser, J R Hudson, A M Murphy, Y E Cossart.   

Abstract

Rubella vaccination of schoolgirls aged 10-14 years started 13 years ago in Australia; the girls were vaccinated without prior assessment of their immunity. Non-pregnant seronegative women were also offered vaccination in family-planning clinics and post partum in obstetric units. Serological follow-up of 191 schoolgirls 5 years after vaccination and 56 girls 8 years after vaccination showed that all had detectable rubella antibody, whereas 24% of 239 unvaccinated young men of similar age (18-23 years) were seronegative. In 1983, 96% of 8226 pregnant women aged 12-53 years (mean 25.3 years) had detectable rubella antibody, and since 1977 there has been a striking reduction in the incidence of deafness due to congenital rubella. These results indicate that the rubella vaccination programme in Australia is having a significant impact on both the serological status of pregnant women and on the incidence of congenital infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143984     DOI: 10.1016/s0140-6736(84)91461-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  Rubella in the developing world.

Authors:  C L Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.

Authors:  C Pelissero; C Marena; F Aguzzi; M Bevilacqua; F Rebasti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

3.  The decline in congenital rubella syndrome in Western Australia: an impact of the school girl vaccination program?

Authors:  F J Stanley; M Sim; G Wilson; S Worthington
Journal:  Am J Public Health       Date:  1986-01       Impact factor: 9.308

4.  Hearing impairment among 10-year-old children: metropolitan Atlanta, 1985 through 1987.

Authors:  C D Drews; M Yeargin-Allsopp; C C Murphy; P Decouflé
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

5.  Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays.

Authors:  P R Field; D W Ho; A L Cunningham
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.